7024 Phase Ib dose-finding trial of intravenous (i.v.) panobinostat (PAN) with docetaxel (DOC) and prednisone (PRED) in patients (pts) with castration resistant prostate cancer (CRPC) Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Vaishampayan, U
  • Rathkopf, D
  • Chi, KN
  • Hotte, Sebastien
  • Vogelzang, N
  • Alumkal, J
  • Agrawal, M
  • Picus, J
  • Fandi, A
  • Scher, HI

publication date

  • September 2009